Yan Qing
PharmTao, Santa Clara, CA 95056-5672, USA and University of Phoenix, Phoenix, AZ, USA.
Per Med. 2011 Nov;8(6):641-649. doi: 10.2217/pme.11.69.
With its multidimensional features and systems biology approaches, developments in psychoneuroimmunology may provide the basis for the translation of scientific discoveries into personalized and systems medicine. To achieve this goal, several key issues need to be emphasized and resolved. These key issues include the identification of biomarkers for accurate diagnosis and treatment, the understanding of the systems interactions and networks, and the systemic profiling of patient subgroups. Recognition of systemic biomarkers may provide insight into the complex multidirectional interactions among psychological and behavioral factors, the nervous system and the immune system. Systems biology studies of complex mechanisms such as inflammation at various levels may enable the discovery of common targets for different diseases from depression to cancer. Such elucidation would enable the classification of patient patterns and subgroups for personalized interventions. Understanding of these key issues would contribute to the establishment of systems models and the development of integrative prevention and treatment strategies in multiple dimensions.
凭借其多维特征和系统生物学方法,心理神经免疫学的发展可能为将科学发现转化为个性化和系统医学提供基础。为实现这一目标,需要强调并解决几个关键问题。这些关键问题包括识别用于准确诊断和治疗的生物标志物、理解系统间的相互作用和网络,以及对患者亚组进行系统分析。识别系统性生物标志物可能有助于深入了解心理和行为因素、神经系统与免疫系统之间复杂的多向相互作用。对炎症等复杂机制在各个层面进行系统生物学研究,可能会发现从抑郁症到癌症等不同疾病的共同靶点。这样的阐释将有助于对患者模式和亚组进行分类,以实施个性化干预。对这些关键问题的理解将有助于建立系统模型,并在多个维度上制定综合预防和治疗策略。